Clinical Trial

Study to Evaluate the Maximal Use of Ruxolitinib Cream in Adult and Adolescent Participants With Hidradenitis Suppurativa

Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
The purpose of this study is to evaluate the maximal use of ruxolitinib cream in adult and adolescent participants with hidradenitis suppurativa.
Protocol Amendment History 13 amendments
This ClinicalTrials.gov record has been amended 13 times since 2025-06-25; most recent amendment 2026-07-20.
Status change: Not Yet Recruiting → Recruiting 2025-09-02
Trial Details
NCT Number NCT07049575
Lead Sponsor Incyte Corporation
Conditions Hidradenitis Suppurativa
Enrollment 24 participants
Start Date 2025-11-03
Primary Completion 2026-12-09 (estimated)
Study Completion 2026-12-09 (estimated)
Updated on ClinicalTrials.gov 2026-08-06